Irhythm Technologies Inc. (IRTC)
iRhythm Technologies, Inc. (IRTC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
iRhythm Technologies, Inc. (IRTC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
iRhythm Technologies, Inc. (IRTC) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
iRhythm Technologies, Inc. (IRTC) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
iRhythm: The Heart Monitor Maker Whose Stock Keeps Beating
iRhythm Technologies stock has doubled this year.
iRhythm Technologies, Inc. (IRTC) Q3 2025 Earnings Call Transcript
iRhythm Technologies, Inc. ( IRTC ) Q3 2025 Earnings Call October 30, 2025 4:30 PM EDT Company Participants Stephanie Zhadkevich - Director of Investor Relations Quentin Blackford - President, CEO & Director Daniel Wilson - CFO & Principal Financial Officer Conference Call Participants Nathan Treybeck - Wells Fargo Securities, LLC, Research Division Richard Newitter - Truist Securities, Inc., Research Division David Saxon - Needham & Company, LLC, Research Division Sam Eiber - BTIG, LLC, Research Division Suraj Kalia - Oppenheimer & Co. Inc., Research Division David Rescott - Robert W. Baird & Co. Incorporated, Research Division Stephanie Piazzola - BofA Securities, Research Division Max Kruszeski - William Blair & Company L.L.C.
iRhythm Technologies (IRTC) Reports Q3 Loss, Beats Revenue Estimates
iRhythm Technologies (IRTC) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to a loss of $1.26 per share a year ago.
iRhythm Technologies, Inc. (IRTC) Q2 2025 Earnings Call Transcript
iRhythm Technologies, Inc. (NASDAQ:IRTC ) Q2 2025 Earnings Conference Call July 31, 2025 4:30 PM ET Company Participants Daniel G. Wilson - CFO & Principal Financial Officer Quentin S.
iRhythm Technologies (IRTC) Reports Q2 Loss, Tops Revenue Estimates
iRhythm Technologies (IRTC) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to a loss of $0.61 per share a year ago.
Will iRhythm Technologies (IRTC) Report Negative Earnings Next Week? What You Should Know
iRhythm Technologies (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
iRhythm Technologies, Inc. (IRTC) Q1 2025 Earnings Call Transcript
iRhythm Technologies, Inc. (NASDAQ:IRTC ) Q1 2025 Earnings Conference Call May 1, 2025 4:30 PM ET Company Participants Stephanie Zhadkevich - Director, IR Quentin Blackford - President & CEO Daniel Wilson - CFO Conference Call Participants Allen Gong - JPMorgan Kallum Titchmarsh - Morgan Stanley Macauley Kilbane - William Blair Nathan Treybeck - Wells Fargo David Rescott - Baird David Saxon - Needham & Company Suraj Kalia - Oppenheimer Jon Young - Canaccord Genuity Sam Eiber - BTIG Richard Newitter - Truist Operator Good afternoon. Thank you for attending the iRhythm Technologies, Inc. First Quarter 2025 Earnings Conference Call.
IRhythm Technologies (IRTC) Reports Q1 Loss, Tops Revenue Estimates
IRhythm Technologies (IRTC) came out with a quarterly loss of $0.95 per share versus the Zacks Consensus Estimate of a loss of $0.89. This compares to loss of $1.47 per share a year ago.
iRhythm Technologies (IRTC) Upgraded to Buy: Here's What You Should Know
iRhythm Technologies (IRTC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
iRhythm Technologies, Inc. (IRTC) Q4 2024 Earnings Call Transcript
iRhythm Technologies, Inc. (NASDAQ:IRTC ) Q4 2024 Earnings Conference Call February 20, 2025 4:30 PM ET Company Participants Stephanie Zhadkevich - Director, IR Quentin Blackford - President & CEO Daniel Wilson - CFO Conference Call Participants Macauley Kilbane - William Blair Lilia-Celine Lozada - JPMorgan Kallum Titchmarsh - Morgan Stanley Nathan Treybeck - Wells Fargo David Roman - Goldman Sachs Sam Eiber - BTIG Jon Young - Canaccord Genuity David Rescott - Baird Suraj Kalia - Oppenheimer Felipe Lamar - Truist Paige Chamberlain - Wolfe Research Operator Good afternoon. Thank you for attending today's iRhythm Technologies Q4 2024 Earnings Conference Call.
